178 related articles for article (PubMed ID: 32381297)
1. Priming and Propagating Anti-tumor Immunity: Focal Hypofractionated Radiation for in Situ Vaccination and Systemic Targeted Radionuclide Theranostics for Immunomodulation of Tumor Microenvironments.
Jagodinsky JC; Morris ZS
Semin Radiat Oncol; 2020 Apr; 30(2):181-186. PubMed ID: 32381297
[TBL] [Abstract][Full Text] [Related]
2. Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity
van den Bijgaart RJE; Schuurmans F; Fütterer JJ; Verheij M; Cornelissen LAM; Adema GJ
Front Immunol; 2021; 12():617365. PubMed ID: 33936033
[No Abstract] [Full Text] [Related]
3. Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.
Marciscano AE; Haimovitz-Friedman A; Lee P; Tran PT; Tomé WA; Guha C; Spring Kong FM; Sahgal A; El Naqa I; Rimner A; Marks LB; Formenti SC; DeWeese TL
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):35-52. PubMed ID: 30836168
[No Abstract] [Full Text] [Related]
4. Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.
Patel RB; Baniel CC; Sriramaneni RN; Bradley K; Markovina S; Morris ZS
Brachytherapy; 2018; 17(6):995-1003. PubMed ID: 30078541
[TBL] [Abstract][Full Text] [Related]
5.
Baniel CC; Heinze CM; Hoefges A; Sumiec EG; Hank JA; Carlson PM; Jin WJ; Patel RB; Sriramaneni RN; Gillies SD; Erbe AK; Schwarz CN; Pieper AA; Rakhmilevich AL; Sondel PM; Morris ZS
Front Immunol; 2020; 11():1610. PubMed ID: 32849544
[TBL] [Abstract][Full Text] [Related]
6. An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy.
Zhang H; Liu L; Yu D; Kandimalla ER; Sun HB; Agrawal S; Guha C
PLoS One; 2012; 7(5):e38111. PubMed ID: 22666458
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Specific Inhibition of
Morris ZS; Guy EI; Werner LR; Carlson PM; Heinze CM; Kler JS; Busche SM; Jaquish AA; Sriramaneni RN; Carmichael LL; Loibner H; Gillies SD; Korman AJ; Erbe AK; Hank JA; Rakhmilevich AL; Harari PM; Sondel PM
Cancer Immunol Res; 2018 Jul; 6(7):825-834. PubMed ID: 29748391
[No Abstract] [Full Text] [Related]
8. Novel Radiation Therapy Paradigms and Immunomodulation: Heresies and Hope.
Dutt S; Ahmed MM; Loo BW; Strober S
Semin Radiat Oncol; 2020 Apr; 30(2):194-200. PubMed ID: 32381299
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade.
Zhang Y; Sriramaneni RN; Clark PA; Jagodinsky JC; Ye M; Jin W; Wang Y; Bates A; Kerr CP; Le T; Allawi R; Wang X; Xie R; Havighurst TC; Chakravarty I; Rakhmilevich AL; O'Leary KA; Schuler LA; Sondel PM; Kim K; Gong S; Morris ZS
Nat Commun; 2022 Aug; 13(1):4948. PubMed ID: 35999216
[TBL] [Abstract][Full Text] [Related]
10. Role of Local Radiation Therapy in Cancer Immunotherapy.
Demaria S; Golden EB; Formenti SC
JAMA Oncol; 2015 Dec; 1(9):1325-32. PubMed ID: 26270858
[TBL] [Abstract][Full Text] [Related]
11. The impact of radiation therapy on the antitumor immunity: local effects and systemic consequences.
Lumniczky K; Sáfrány G
Cancer Lett; 2015 Jan; 356(1):114-25. PubMed ID: 23994343
[TBL] [Abstract][Full Text] [Related]
12. Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy.
Sun Z; Chu Y; Xiao J; Yang Y; Meng F; Wang X; Dong Y; Zhu J; Wu Y; Qin L; Ke Y; Liu B; Liu Q
J Transl Med; 2023 Sep; 21(1):619. PubMed ID: 37700338
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain.
Clark PA; Sriramaneni RN; Bates AM; Jin WJ; Jagodinsky JC; Hernandez R; Le T; Jeffery JJ; Marsh IR; Grudzinski JJ; Aluicio-Sarduy E; Barnhart TE; Anderson BR; Chakravarty I; Arthur IS; Kim K; Engle JW; Bednarz BP; Weichert JP; Morris ZS
Radiat Res; 2021 Jun; 195(6):522-540. PubMed ID: 33826741
[TBL] [Abstract][Full Text] [Related]
14. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
15. Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.
Chang MC; Chen YL; Lin HW; Chiang YC; Chang CF; Hsieh SF; Chen CA; Sun WZ; Cheng WF
Mol Ther; 2018 Feb; 26(2):404-419. PubMed ID: 29248428
[TBL] [Abstract][Full Text] [Related]
16. In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.
Morris ZS; Guy EI; Francis DM; Gressett MM; Werner LR; Carmichael LL; Yang RK; Armstrong EA; Huang S; Navid F; Gillies SD; Korman A; Hank JA; Rakhmilevich AL; Harari PM; Sondel PM
Cancer Res; 2016 Jul; 76(13):3929-41. PubMed ID: 27197149
[TBL] [Abstract][Full Text] [Related]
17. Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination.
Carlson PM; Patel RB; Birstler J; Rodriquez M; Sun C; Erbe AK; Bates AM; Marsh I; Grudzinski J; Hernandez R; Pieper AA; Feils AS; Rakhmilevich AL; Weichert JP; Bednarz BP; Sondel PM; Morris ZS
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36639155
[TBL] [Abstract][Full Text] [Related]
18.
De La Maza L; Wu M; Wu L; Yun H; Zhao Y; Cattral M; McCart A; Cho BJ; de Perrot M
Clin Cancer Res; 2017 Sep; 23(18):5502-5513. PubMed ID: 28606922
[No Abstract] [Full Text] [Related]
19. Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.
Magee K; Marsh IR; Turek MM; Grudzinski J; Aluicio-Sarduy E; Engle JW; Kurzman ID; Zuleger CL; Oseid EA; Jaskowiak C; Albertini MR; Esbona K; Bednarz B; Sondel PM; Weichert JP; Morris ZS; Hernandez R; Vail DM
PLoS One; 2021; 16(8):e0255798. PubMed ID: 34383787
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend.
Locy H; de Mey S; de Mey W; De Ridder M; Thielemans K; Maenhout SK
Front Immunol; 2018; 9():2909. PubMed ID: 30619273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
